These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1225 related articles for article (PubMed ID: 33510275)

  • 21. Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein.
    Tani H; Kimura M; Tan L; Yoshida Y; Ozawa T; Kishi H; Fukushi S; Saijo M; Sano K; Suzuki T; Kawasuji H; Ueno A; Miyajima Y; Fukui Y; Sakamaki I; Yamamoto Y; Morinaga Y
    Virol J; 2021 Jan; 18(1):16. PubMed ID: 33435994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents.
    Garrido C; Hurst JH; Lorang CG; Aquino JN; Rodriguez J; Pfeiffer TS; Singh T; Semmes EC; Lugo DJ; Rotta AT; Turner NA; Burke TW; McClain MT; Petzold EA; Permar SR; Moody MA; Woods CW; Kelly MS; Fouda GG
    JCI Insight; 2021 Sep; 6(17):. PubMed ID: 34228642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associating SARS-CoV-2 Serological Assays with Protection: Where the Field Stands.
    Tang MS; Farnsworth CW
    Clin Chem; 2021 Apr; 67(5):707-709. PubMed ID: 33772260
    [No Abstract]   [Full Text] [Related]  

  • 24. Early and High SARS-CoV-2 Neutralizing Antibodies Are Associated with Severity in COVID-19 Patients from India.
    Shrivastava S; Palkar S; Shah J; Rane P; Lalwani S; Mishra AC; Arankalle VA
    Am J Trop Med Hyg; 2021 Jun; 105(2):401-406. PubMed ID: 34138748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-Term Humoral Immune Response in Persons with Asymptomatic or Mild SARS-CoV-2 Infection, Vietnam.
    Mai HK; Trieu NB; Long TH; Thanh HT; Luong ND; Huy LX; Nguyet LA; Man DNH; Anderson DE; Thanh TT; Chau NVV; Thwaites G; Wang LF; Van Tan L; Hung DT
    Emerg Infect Dis; 2021 Feb; 27(2):663-666. PubMed ID: 33496647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody response to SARS-CoV-2 in infected patients with different clinical outcome.
    Anichini G; Gandolfo C; Terrosi C; Fabrizi S; Miceli GB; Gori Savellini G; Prathyumnan S; Franchi F; Cusi MG
    J Med Virol; 2021 Apr; 93(4):2548-2552. PubMed ID: 33427302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans.
    Vanshylla K; Di Cristanziano V; Kleipass F; Dewald F; Schommers P; Gieselmann L; Gruell H; Schlotz M; Ercanoglu MS; Stumpf R; Mayer P; Zehner M; Heger E; Johannis W; Horn C; Suárez I; Jung N; Salomon S; Eberhardt KA; Gathof B; Fätkenheuer G; Pfeifer N; Eggeling R; Augustin M; Lehmann C; Klein F
    Cell Host Microbe; 2021 Jun; 29(6):917-929.e4. PubMed ID: 33984285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of SARS-CoV2 humoral response including neutralizing antibodies is not sufficient to protect patients against fatal infection.
    Choteau M; Scohy A; Messe S; Luyckx M; Dechamps M; Montiel V; Yombi JC; Gruson D; Limaye N; Michiels T; Dumoutier L
    Sci Rep; 2022 Feb; 12(1):2077. PubMed ID: 35136139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal Assessment of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immune Responses for Six Months Based on the Clinical Severity of Coronavirus Disease 2019.
    Noh JY; Kwak JE; Yang JS; Hwang SY; Yoon JG; Seong H; Hyun H; Lim CS; Yoon SY; Ryou J; Lee JY; Kim SS; Park SH; Cheong HJ; Kim WJ; Shin EC; Song JY
    J Infect Dis; 2021 Sep; 224(5):754-763. PubMed ID: 34467985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occurrence of COVID-19 Symptoms During SARS-CoV-2 Infection Defines Waning of Humoral Immunity.
    Wu J; Liang BY; Fang YH; Wang H; Yang XL; Shen S; Chen LK; Li SM; Lu SH; Xiang TD; Liu J; Le-Trilling VTK; Lu MJ; Yang DL; Deng F; Dittmer U; Trilling M; Zheng X
    Front Immunol; 2021; 12():722027. PubMed ID: 34489971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PASC (Post Acute Sequelae of COVID-19) is associated with decreased neutralizing antibody titers in both biological sexes and increased ANG-2 and GM-CSF in females.
    Jansen EB; Ostadgavahi AT; Hewins B; Buchanan R; Thivierge BM; Sganzerla Martinez G; Goncin U; Francis ME; Swan CL; Scruten E; Bell J; Darbellay J; Facciuolo A; Falzarano D; Gerdts V; Fenton ME; Hedlin P; Kelvin DJ; Kelvin AA
    Sci Rep; 2024 Apr; 14(1):9854. PubMed ID: 38684819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study.
    Karuna S; Li SS; Grant S; Walsh SR; Frank I; Casapia M; Trahey M; Hyrien O; Fisher L; Miner MD; Randhawa AK; Polakowski L; Kublin JG; Corey L; Montefiori D;
    PLoS Med; 2021 Dec; 18(12):e1003868. PubMed ID: 34871308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age, Disease Severity and Ethnicity Influence Humoral Responses in a Multi-Ethnic COVID-19 Cohort.
    Smith M; Abdesselem HB; Mullins M; Tan TM; Nel AJM; Al-Nesf MAY; Bensmail I; Majbour NK; Vaikath NN; Naik A; Ouararhni K; Mohamed-Ali V; Al-Maadheed M; Schell DT; Baros-Steyl SS; Anuar ND; Ismail NH; Morris PE; Mamat RNR; Rosli NSM; Anwar A; Ellan K; Zain RM; Burgers WA; Mayne ES; El-Agnaf OMA; Blackburn JM
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33925055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential serological and neutralizing antibody dynamics after an infection by a single SARS-CoV-2 strain.
    Billon-Denis E; Ferrier-Rembert A; Garnier A; Cheutin L; Vigne C; Tessier E; Denis J; Badaut C; Rougeaux C; Depeille Wuille A; Timera H; Boutin LI; Drouet I; Verguet N; Nolent F; Gorgé O; Ferraris O; Tournier JN
    Infection; 2021 Aug; 49(4):781-783. PubMed ID: 33387262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutralizing antibody titres in SARS-CoV-2 infections.
    Lau EHY; Tsang OTY; Hui DSC; Kwan MYW; Chan WH; Chiu SS; Ko RLW; Chan KH; Cheng SMS; Perera RAPM; Cowling BJ; Poon LLM; Peiris M
    Nat Commun; 2021 Jan; 12(1):63. PubMed ID: 33397909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brief Research Report: Virus-Specific Humoral Immunity at Admission Predicts the Development of Respiratory Failure in Unvaccinated SARS-CoV-2 Patients.
    Tajuelo A; Carretero O; García-Ríos E; López-Siles M; Cano O; Vázquez M; Más V; Rodríguez-Goncer I; Lalueza A; López-Medrano F; Juan RS; Fernández-Ruiz M; Aguado JM; McConnell MJ; Pérez-Romero P
    Front Immunol; 2022; 13():878812. PubMed ID: 35547738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific COVID-19 Symptoms Correlate with High Antibody Levels against SARS-CoV-2.
    Amjadi MF; O'Connell SE; Armbrust T; Mergaert AM; Narpala SR; Halfmann PJ; Bashar SJ; Glover CR; Heffron AS; Taylor A; Flach B; O'Connor DH; Kawaoka Y; McDermott AB; Sethi AK; Shelef MA
    Immunohorizons; 2021 Jun; 5(6):466-476. PubMed ID: 34398806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-Term Existence of SARS-CoV-2 in COVID-19 Patients: Host Immunity, Viral Virulence, and Transmissibility.
    Wang X; Huang K; Jiang H; Hua L; Yu W; Ding D; Wang K; Li X; Zou Z; Jin M; Xu S
    Virol Sin; 2020 Dec; 35(6):793-802. PubMed ID: 33156486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection.
    Choe PG; Kang CK; Suh HJ; Jung J; Song KH; Bang JH; Kim ES; Kim HB; Park SW; Kim NJ; Park WB; Oh MD
    Emerg Infect Dis; 2021 Jan; 27(1):327-9. PubMed ID: 33050983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals.
    Ni L; Ye F; Cheng ML; Feng Y; Deng YQ; Zhao H; Wei P; Ge J; Gou M; Li X; Sun L; Cao T; Wang P; Zhou C; Zhang R; Liang P; Guo H; Wang X; Qin CF; Chen F; Dong C
    Immunity; 2020 Jun; 52(6):971-977.e3. PubMed ID: 32413330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.